Bottom line
How much do FHLC and HIAHX overlap?
71% of their top holdings overlap by weight. 19 securities appear in both funds' top 25, making up 60.9% of FHLC's assets and 62.2% of HIAHX's. They are largely the same portfolio — owning both adds little diversification.
FHLC holds far more positions (337 vs 79), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and HIAHX have in common
| Holding | % of FHLC | % of HIAHX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 12.47% | 12.47% |
| Johnson & Johnson | 8.93% | 6.63% | 6.63% |
| AbbVie Inc | 6.42% | 3.43% | 3.43% |
| UnitedHealth Group Inc | 5.44% | 4.72% | 4.72% |
| Merck & Co Inc | 4.66% | 6.60% | 4.66% |
| Thermo Fisher Scientific Inc | 3.09% | 1.64% | 1.64% |
| Abbott Laboratories | 2.66% | 2.10% | 2.10% |
| CVS Health Corp | 1.92% | 2.93% | 1.92% |
| Intuitive Surgical Inc | 1.82% | 2.99% | 1.82% |
| Danaher Corp | 1.80% | 2.65% | 1.80% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.69% | 1.76% |
| Stryker Corp | 1.62% | 1.17% | 1.17% |
| Medtronic PLC | 1.59% | 1.02% | 1.02% |
| Elevance Health Inc | 1.19% | 2.96% | 1.19% |
| Regeneron Pharmaceuticals Inc | 1.15% | 1.52% | 1.15% |
| Boston Scientific Corp | 1.00% | 1.19% | 1.00% |
| HCA Healthcare Inc | 0.91% | 1.60% | 0.91% |
| Cencora Inc | 0.83% | 2.07% | 0.83% |
| Cardinal Health Inc | 0.78% | 1.81% | 0.78% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Amgen Inc — 3.00%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
- Bristol-Myers Squibb Co — 1.93%
- McKesson Corp — 1.52%
- Cigna Group/The — 1.06%
Only in HIAHX
- Edwards Lifesciences Corp — 2.42%
- Biogen Inc — 1.41%
- Agilent Technologies Inc — 1.36%
- Gsk Plc — 1.21%
- Centene Corp — 1.16%
- United Therapeutics Corp — 0.96%
Asset mix
| Asset type | FHLC | HIAHX |
|---|---|---|
| Stocks | 99.7% | 96.8% |
| Repurchase agreements | — | 0.7% |
| Cash & short-term funds | 0.2% | 0.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FHLC | HIAHX |
|---|---|---|
| US | 96.5% | 87.9% |
| IE | 2.2% | 2.3% |
| GB | 0.5% | 2.3% |
| NL | 0.1% | 1.8% |
| BE | — | 0.8% |
| DK | — | 0.8% |
| CN | — | 0.6% |
| CH | 0.1% | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FHLC and HIAHX overlap?
What stocks do FHLC and HIAHX have in common?
Should I own both FHLC and HIAHX?
Which holds more stocks, FHLC or HIAHX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.